Healthcare - Biotechnology - NASDAQ - US
$ 1.29
-3.01 %
$ 68 M
Market Cap
-0.43
P/E
BALANCE SHEET
243 M
ASSETS
52.8 M
LIABILITIES
190 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
ALX Oncology Holdings Inc.
| Current Assets | 189 M |
| Cash & Short-Term Investments | 183 M |
| Receivables | 0 |
| Other Current Assets | 5.92 M |
| Non-Current Assets | 53.9 M |
| Long-Term Investments | 35.4 M |
| PP&E | 10.8 M |
| Other Non-Current Assets | 7.64 M |
| Current Liabilities | 36 M |
| Accounts Payable | 8.59 M |
| Short-Term Debt | 1.58 M |
| Other Current Liabilities | 25.8 M |
| Non-Current Liabilities | 16.8 M |
| Long-Term Debt | 15.6 M |
| Other Non-Current Liabilities | 1.22 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 22.4 | 282.9 | 363.7 | 434.2 | 9.0 | 8.3 |
| Short Term Investments | 160.3 | 217.4 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0.5 | 0.9 |
| Inventory | 0 | (17.7) | 0 | 0 | 0 | 0 |
| Other Current Assets | 5.9 | 4.8 | 6.7 | 3.5 | 0.3 | 1.0 |
| Total Current Assets | 188.7 | 271.0 | 367.0 | 434.2 | 9.8 | 10.2 |
| PP&E | 10.8 | 9.8 | 3.5 | 52 K | 0.9 | 1.0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 35.4 | 16.7 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 7.6 | 9.0 | 9.7 | 1.8 | 7 K | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 242.6 | 306.5 | 380.2 | 436.1 | 10.7 | 11.2 |
| LIABILITIES | ||||||
| Accounts Payable | 8.6 | 8.1 | 3.8 | 4 K | 3.7 | 0.7 |
| Short Term Debt | 1.6 | 1.0 | 0.7 | 0 | 0 | 0 |
| Other Current Liabilities | 25.8 | 19.2 | 10.8 | 6.0 | 1.2 | 1.2 |
| Total Current Liabilities | 36.0 | 28.3 | 15.3 | 6.2 | 5.0 | 1.9 |
| Long Term Debt | 15.6 | 9.4 | 0 | 0 | 5.4 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 1.2 | 5.3 | 1.8 | 5 K | 0.5 | 0 |
| Total Liabilities | 52.8 | 43.0 | 17.1 | 436.1 | 11.0 | 2.0 |
| EQUITY | ||||||
| Common Stock | 50 K | 41 K | 41 K | 40 K | 3 K | 3 K |
| Retained Earnings | (486.3) | (325.5) | (202.0) | (118.5) | (72.8) | (53.5) |
| Other Accumulative Comprehensive Income/Loss | 0.3 | (0.8) | 0 | (554.6) | 0 | (1.0) |
| Total Equity | 189.7 | (325.5) | (202.0) | (118.5) | (0.3) | 9.2 |
| Total Liabilities and Equity | 242.6 | (282.4) | (184.9) | 436.1 | 10.7 | 11.2 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 43.0 | 40.7 | 40.3 | 39.8 | 36.5 | 22.0 |